Analysis of Glycemic Control in Type 1 Diabetes Patients Using Hybrid Closed Loop Insulin Pump Therapy (Medtronic 670G)

Completed

Conditions studied: Biomedical Technology, Type 1 Diabetes

In brief

Observational study of patients at Boston Childrens Hospital with type 1 diabetes (T1D) who elected to treat their diabetes with the Medtronic 670 G hybrid closed loop insulin pump.

Key facts

Study ID

NCT04051632

Run by

Boston Children's Hospital

People needed

96

Starts

2018-06-13

Expected to finish

2019-07-30

Last updated by the study team

2019-08-09

Who can join

Age: 5 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• clinical diagnosis of T1D
• patient of Boston Childrens Hospital diabetes program
• deemed to be adequate candidates for hybrid closed loop technology by their diabetes health care team
• patient received Medtronic 670G training at Boston Childrens Hospital
• patient received follow up diabetes care at Boston Childrens Hospital for at least 3 months after starting on the 670G

You may not qualify if…

• patients not trained at Boston Childrens Hospital or self started

Where it is running

• Boston Childrens Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.